CRDL
CRD-A-144A-S-AI (CRDL)
NASDAQ
$1.19+$0.07 (+6.61%)
Price as of Jun 03, 2026 7:59 PM EDT
  • $140.6M
    Market Cap
  • -22.76%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
78,760
0.00%
78,760
0.00%
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
-100.00%
78,760
0.00%
78,760
0.00%
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-14.0M
+0.05%
-14.0M
-1.49%
-14.2M
-24.99%
-19.0M
+74.44%
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
20.3M
-22.72%
26.3M
+68.78%
15.6M
-30.45%
22.4M
-19.73%
Operating Profit
-34.3M
-14.80%
-40.3M
+35.22%
-29.8M
-27.94%
-41.3M
+6.91%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
28,223
0.00%
28,223
-81.15%
149,739
-8.94%
164,443
+46.52%
Income before Taxes
-33.8M
-7.79%
-36.7M
+30.39%
-28.1M
-9.06%
-30.9M
-2.24%
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-33.8M
-7.79%
-36.7M
+30.39%
-28.1M
-9.06%
-30.9M
-2.24%
Net Income from Continuing Operations Applicable to Common
-33.8M
-7.79%
-36.7M
+30.39%
-28.1M
-9.06%
-30.9M
-2.24%
Basic EPS and Net Income
-0.39
-23.53%
-0.51
+15.91%
-0.44
-10.20%
-0.49
-32.88%
Diluted EPS and Net Income
-0.39
-23.53%
-0.51
+15.91%
-0.44
-10.20%
-0.49
-32.88%
Basic Weighted Average Shares
87.0M
+21.55%
71.6M
+11.02%
64.5M
+3.13%
62.5M
+44.61%
Diluted Weighted Average Shares
87.0M
+21.55%
71.6M
+11.02%
64.5M
+3.13%
62.5M
+44.61%
Balance Sheet
Cash and Cash Equivalents
21.4M
-29.97%
30.6M
-12.46%
34.9M
-41.26%
59.5M
-29.12%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
21.4M
-29.97%
30.6M
-12.46%
34.9M
-41.26%
59.5M
-29.12%
Total Current Assets
23.5M
-25.79%
31.7M
-12.41%
36.2M
-41.16%
61.4M
-29.50%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
118,093
-39.62%
195,592
-41.97%
337,058
+13.97%
295,738
-17.04%
Total Long-Term Assets
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Assets
23.6M
-25.87%
31.9M
-13.18%
36.7M
-40.83%
62.0M
-29.41%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
5.7M
-19.33%
7.0M
-15.50%
8.3M
-15.39%
9.8M
-15.22%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Liabilities
5.7M
-19.52%
7.1M
-15.60%
8.5M
-13.97%
9.8M
-15.56%
Retained Earnings
-213.1M
+18.87%
-179.3M
+25.72%
-142.6M
+24.58%
-114.4M
+37.03%
Total Stockholders Equity
17.9M
-27.70%
24.7M
-12.45%
28.2M
-45.89%
52.2M
-31.53%
Total Shares Outstanding
100.3M
+21.36%
82.6M
+26.41%
65.4M
+2.05%
64.0M
+3.42%
Cash Flow
Cash from Operating Activities
-23.9M
-4.81%
-25.1M
-0.47%
-25.2M
-7.49%
-27.2M
+15.58%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
-24,484
+15.00%
-21,290
-66.90%
-64,312
-13.92%
-74,709
+478.42%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
15.5M
-17.52%
18.8M
+34,122.57%
-55,376
+2.67%
-53,934
-100.06%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
-37,818.06%
-27.94%
-52,483.34%
N/A
Return on Assets
-121.91%
+13.94%
-106.99%
+87.76%
-56.98%
+38.08%
-41.27%
N/A
Return on Equity
-158.75%
+14.65%
-138.47%
+98.02%
-69.93%
+45.19%
-48.16%
N/A
Revenue Growth
N/A
N/A
N/A
N/A
0.00%
N/A
0.00%
N/A
Current Ratio
4.16
-8.01%
4.52
+3.66%
4.36
-30.45%
6.27
N/A
Cash Ratio
3.79
-13.19%
4.36
+3.60%
4.21
-30.58%
6.07
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow